x

Search for a clinical trial

* (*) mandatory field

Clinical Gene Therapy Protocol for the Treatment of Retinal Dystrophy Caused by Defects in RPE65 - FR

  • Type of clinical trial : Gene therapy clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funding body(ies) :
  • CHU NANTES, AFM (ASSOCIATION FRANÇAISE CONTRE LES MYOPATHIES)
  • Geographic coverage : National
  • Sponsor : Chu nantes
  • Principal investigator of clinical trial

  • Pr Michel WEBER
  • Service d'ophtalmologie
  • CHU de Nantes - Hôtel Dieu
  • 1 place Alexis Ricordeau
  • 44093 NANTES CEDEX 1
  • FRANCE
  • More information
  • Phone  : 33 (0)2 40 08 34 01
  • Fax  : 33 (0)2 40 08 46 50
  • Website
  • Investigator of clinical trial

  • Ms Anne OMNES
  • CHU Nantes
  • CHU de Nantes
  • 5 Allée de l'Ile Gloriette
  • 44093 NANTES CEDEX 1
  • FRANCE
  • More information
  • Phone  : 33 (0)2 53 48 28 35
  • Fax  : 33 (0)2 53 48 28 36
  • Website
  • Sponsor of clinical trial

  • CHU NANTES
  • CHU Nantes
  • CHU de Nantes
  • 5 Allée de l'Ile Gloriette
  • 44093 NANTES CEDEX 1
  • FRANCE
  • More information
  • Phone  : 33 (0)2 53 48 28 35
  • Fax  : 33 (0)2 53 48 28 36
  • Website
  • Public funding body

  • CHU NANTES
  • CHU Nantes
  • CHU de Nantes
  • 5 Allée de l'Ile Gloriette
  • 44093 NANTES CEDEX 1
  • FRANCE
  • More information
  • Phone  : 33 (0)2 53 48 28 35
  • Fax  : 33 (0)2 53 48 28 36
  • Website
Last update: November 2014

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.